News

A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...
The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency’s drug program, the ...
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...
The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency's drug program, the latest in a string of leadership changes at the agency.
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...
Sarepta Therapeutics shares traded lower in premarket trade on Tuesday, as the drugmaker relented to a Food and Drug ...
U.S. Food and Drug Administration commissioner Marty Makary has appointed former biotech executive George Tidmarsh as the ...
The company agreed to voluntarily halt shipments of its experimental medicine Elevidys for Duchenne muscular dystrophy.
The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...